Related Experiment Video
Updated: Jul 28, 2026

12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Evidence against extrapancreatic insulin synthesis
Summary
Insulin is not synthesized in brain or other extrapancreatic tissues. The kidney is the only organ besides the pancreas where insulin levels are significantly high, suggesting limited insulin distribution.
Area of Science:
- Biochemistry
- Endocrinology
- Neuroscience
Background:
- Insulin is a crucial hormone regulating glucose metabolism.
- Understanding insulin distribution in non-pancreatic tissues is vital for metabolic research.
- Previous studies have yielded conflicting results on extrapancreatic insulin synthesis.
Purpose of the Study:
- To develop a sensitive method for quantifying insulin in tissue extracts.
- To determine the presence and concentration of insulin in various extrapancreatic tissues.
- To investigate the potential for extrapancreatic insulin synthesis.
Main Methods:
- A hydrophobic adsorption technique was employed to concentrate insulin from acid/ethanol tissue extracts.
- Octadecylsilyl silica columns were used for insulin adsorption and elution.
- Quantification of insulin was performed using the developed concentration method.
Main Results:
- Insulin recovery yields exceeded 75% after concentration.
- Insulin levels in brain tissues of rats and rabbits were less than 20% of plasma concentration.
- The kidney showed insulin levels significantly above plasma, while other extrapancreatic organs had undetectable levels.
Conclusions:
- Insulin is not synthesized in brain or other extrapancreatic tissues.
- The kidney is the primary extrapancreatic organ with significant insulin presence.
- Extrapancreatic tissues do not appear to contain significant amounts of insulin or insulin-like materials from other mammals.
More Related Videos
Related Concept Videos
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

